Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 293052011000036115 | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 293053011000036110 | bevacizumab 100 mg/4 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | Is a | bevacizumab | true | Inferred relationship | Some | ||
| bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | has intended active ingredient | bevacizumab | true | Inferred relationship | Some | 1561724718 | |
| bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | has Australian BoSS | bevacizumab | true | Inferred relationship | Some | 1561724718 | |
| bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | has unit of use | vial | true | Inferred relationship | Some | 1561724719 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Zirabev 100 mg/4 mL injection, 4 mL vial | Is a | True | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | Inferred relationship | Some | |
| Mvasi 100 mg/4 mL injection, 4 mL vial | Is a | True | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | Inferred relationship | Some | |
| Bevaciptin 100 mg/4 mL injection, 4 mL vial | Is a | True | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | Inferred relationship | Some | |
| Abevmy 100 mg/4 mL injection, 4 mL vial | Is a | True | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | Inferred relationship | Some | |
| Avastin 100 mg/4 mL injection, 4 mL vial | Is a | True | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | Inferred relationship | Some | |
| bevacizumab 100 mg/4 mL injection, 4 mL vial | has MPUU | True | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR